These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32295675)

  • 1. Tripartite Motif-Containing 46 Promotes Viability and Inhibits Apoptosis of Osteosarcoma Cells by Activating NF-B Signaling Through Ubiquitination of PPAR.
    Jiang W; Cai X; Xu T; Liu K; Yang D; Fan L; Li G; Yu X
    Oncol Res; 2020 Sep; 28(4):409-421. PubMed ID: 32295675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway.
    Lu Y; Sun Y; Zhu J; Yu L; Jiang X; Zhang J; Dong X; Ma B; Zhang Q
    Cell Death Dis; 2018 Jan; 9(1):15. PubMed ID: 29323103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of TNF-α/NF-κB axis enhances CRL4B
    Zhang C; Chen B; Jiang K; Lao L; Shen H; Chen Z
    Mol Oncol; 2018 Apr; 12(4):476-494. PubMed ID: 29377600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
    Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
    Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1.
    Zhou C; Zhang Z; Zhu X; Qian G; Zhou Y; Sun Y; Yu W; Wang J; Lu H; Lin F; Shen Z; Zheng S
    EBioMedicine; 2020 Sep; 59():102955. PubMed ID: 32853985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paeonol antagonizes oncogenesis of osteosarcoma by inhibiting the function of TLR4/MAPK/NF-κB pathway.
    Zhou J; Liu Q; Qian R; Liu S; Hu W; Liu Z
    Acta Histochem; 2020 Jan; 122(1):151455. PubMed ID: 31587886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
    Zhu B; Cheng D; Li S; Zhou S; Yang Q
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Id-1 promotes osteosarcoma cell growth and inhibits cell apoptosis via PI3K/AKT signaling pathway.
    Hao L; Liao Q; Tang Q; Deng H; Chen L
    Biochem Biophys Res Commun; 2016 Feb; 470(3):643-649. PubMed ID: 26797271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM9 overexpression promotes uterine leiomyoma cell proliferation and inhibits cell apoptosis via NF-κB signaling pathway.
    Yang F; Liu H; Yu Y; Xu L
    Life Sci; 2020 Sep; 257():118101. PubMed ID: 32679146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic gene TRIM10 confers resistance to cisplatin in osteosarcoma cells and activates the NF-κB signaling pathway.
    Xi X; Bao Y; Zhou Y; Chen Y; Zhong X; Liao J; Zhou J; Xu S; Cao Z; Hu K; Hu Y; He X; Zhou L; Lin H; Wu Q
    Cell Biol Int; 2021 Jan; 45(1):74-82. PubMed ID: 32997424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.
    Xu G; Guo Y; Xu D; Wang Y; Shen Y; Wang F; Lv Y; Song F; Jiang D; Zhang Y; Lou Y; Meng Y; Yang Y; Kang Y
    Sci Rep; 2017 Feb; 7():42411. PubMed ID: 28205534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of CXCR4 on Apoptosis in Osteosarcoma Cells via the PI3K/Akt/NF-κβ Signaling Pathway.
    Jiang C; Ma S; Hu R; Wang X; Li M; Tian F; Jiang W; Zhu L; Bian Z
    Cell Physiol Biochem; 2018; 46(6):2250-2260. PubMed ID: 29734183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1β/nuclear factor-κB signaling promotes osteosarcoma cell growth through the microRNA-181b/phosphatase and tensin homolog axis.
    Wang W; Wang Z; Chen S; Zang X; Miao J
    J Cell Biochem; 2019 Feb; 120(2):1763-1772. PubMed ID: 30977354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM46 contributes to high glucose-induced ferroptosis and cell growth inhibition in human retinal capillary endothelial cells by facilitating GPX4 ubiquitination.
    Zhang J; Qiu Q; Wang H; Chen C; Luo D
    Exp Cell Res; 2021 Oct; 407(2):112800. PubMed ID: 34487731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM46 activates AKT/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells.
    Tantai J; Pan X; Chen Y; Shen Y; Ji C
    Cell Death Dis; 2022 Mar; 13(3):285. PubMed ID: 35354796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway.
    Shi D; Wu F; Mu S; Hu B; Zhong B; Gao F; Qing X; Liu J; Zhang Z; Shao Z
    J Exp Clin Cancer Res; 2019 Aug; 38(1):375. PubMed ID: 31443665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM52 positively mediates NF-κB to promote the growth of human benign prostatic hyperplasia cells through affecting TRAF2 ubiquitination.
    Sun J; Liu P; Mao J; Han W; Jiang X; Gu Y
    Life Sci; 2020 Oct; 259():118380. PubMed ID: 32898524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-κB pathway.
    Zhang CL; Wang C; Yan WJ; Gao R; Li YH; Zhou XH
    Oncol Rep; 2014 Sep; 32(3):1149-55. PubMed ID: 24969828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression.
    Zeng H; Zhang JM; Du Y; Wang J; Ren Y; Li M; Li H; Cai Z; Chu Q; Yang C
    Oncotarget; 2016 Feb; 7(6):7329-42. PubMed ID: 26797758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM58 Interacts with Pyruvate Kinase M2 to Inhibit Tumorigenicity in Human Osteosarcoma Cells.
    Yuan P; Zhou Y; Wang R; Chen S; Wang Q; Xu Z; Liu Y; Yang H
    Biomed Res Int; 2020; 2020():8450606. PubMed ID: 32219144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.